AAO Commends Congress for Reaching Significant Milestone on Prior Authorization Reform Bill

The American Academy of Ophthalmology stated that is commends the US House of Representatives for surpassing the 290-cosponsor milestone in support of H.R. 3173, the "Improving Seniors’ Timely Access to Care Act of 2021."

AAO Commends Congress for Reaching Significant Milestone on Prior Authorization Reform Bill
May 16, 2022
Spark Therapeutics’ CEO and Founder Jeff Marrazzo Steps Down, COO Ron Philip to Succeed

Spark Therapeutics, a part of the Roche Group, announced that Ron Philip, the company's COO, will take over as CEO from co-founder Jeffrey D. Marrazzo. Mr. Marrazzo, who joined the company as a co-founder in 2013, will step down on April 1.

Spark Therapeutics’ CEO and Founder Jeff Marrazzo Steps Down, COO Ron Philip to Succeed
February 25, 2022
Rayner Acquires Stake in Surgical Instrument Belgian Manufacturer Hasa Optix

Rayner announced that it has entered into a commercial partnership and concurrently acquired a stake in Hasa Optix, a Brussels-based manufacturer of single use ophthalmic surgical instruments and instrument sets.

Rayner Acquires Stake in Surgical Instrument Belgian Manufacturer Hasa Optix
June 09, 2022
VSY Biotechnology to Announce First Clinical Experiences of AcrivaUD Trinova Pro C Pupil Adaptive® at ESCRS Congress

VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, is readying to share the first clinical experiences of AcrivaUD Trinova Pro C Pupil Adaptive®.

VSY Biotechnology to Announce First Clinical Experiences of AcrivaUD Trinova Pro C Pupil Adaptive® at ESCRS Congress
September 12, 2022
Omeros Completes Sale of Omidria Franchise to Rayner Surgical

Omeros has completed the sale of Omidria (phenylephrine and ketorolac intraocular solution) 1.0%/0.3% to Rayner Surgical Group.

Omeros Completes Sale of Omidria Franchise to Rayner Surgical
December 29, 2021
AffaMed Signs Licensing Agreement with Hanmi Pharma for Investigational Dry AMD Treatment in Greater China

AffaMed Therapeutics and Hanmi Pharmaceutical Co. have entered into a licensing agreement, according to a company news release.

AffaMed Signs Licensing Agreement with Hanmi Pharma for Investigational Dry AMD Treatment in Greater China
January 05, 2022
Moria Acquires Alchimia SRL, Expanding its Footprint into Eye Surgery

France-based Moria has acquired Italian-based company Alchimia SRL, a manufacturer of devices for ophthalmic surgery and human tissue banking.

Moria Acquires Alchimia SRL, Expanding its Footprint into Eye Surgery
October 10, 2022
Retina Consultants of America Acquires Retina Center Northwest

Retina Consultants of America (RCA), a physician management services organization, has added Retina Center Northwest (RCNW) in Washington state,.

Retina Consultants of America Acquires Retina Center Northwest
March 29, 2022
Retina Consultants of America Partners with Associated Vitreoretinal and Uveitis Consultants in Indiana

Retina Consultants of America (RCA) has added Associated Vitreoretinal and Uveitis Consultants (AVRUC) to its national consortium.

Retina Consultants of America Partners with Associated Vitreoretinal and Uveitis Consultants in Indiana
April 05, 2022
Weill Cornell Medicine Receives $1.27m Funding to Develop Treatment for Rare Eye Disease

The US Department of Defense (DoD) has awarded Weill Cornell Medicine a $1.27 million grant to develop a treatment for a rare but deadly eye disease that mostly affects military members who have suffered traumatic eye injuries in combat.

Weill Cornell Medicine Receives $1.27m Funding to Develop Treatment for Rare Eye Disease
November 23, 2021
More